Your browser doesn't support javascript.
loading
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
Wevers, M R; Schmidt, M K; Engelhardt, E G; Verhoef, S; Hooning, M J; Kriege, M; Seynaeve, C; Collée, M; van Asperen, C J; Tollenaar, R A E M; Koppert, L B; Witkamp, A J; Rutgers, E J T; Aaronson, N K; Rookus, M A; Ausems, M G E M.
Affiliation
  • Wevers MR; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands, m.wevers@umcutrecht.nl.
Fam Cancer ; 14(3): 355-63, 2015 Sep.
Article in En | MEDLINE | ID: mdl-25700605
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / BRCA2 Protein / Mastectomy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Fam Cancer Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / BRCA2 Protein / Mastectomy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Fam Cancer Year: 2015 Document type: Article